Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ramm Pharma Corp C.RAMM

Healthcare
RAMM Pharma Corp., through its wholly-owned operating subsidiaries, is engaged in the pharmaceutical and medical product business, and is a leader in the field of cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. With RAMM’s large scale cultivation facility, the combined operations are expected to provide for complete vertical... see more

Recent & Breaking News (CSE:RAMM)

RAMM Pharma Enters European Cannabis Market with Strategic Investment in Canapar Corp.

GlobeNewswire December 30, 2020

RAMM Pharma Commences Epifractán(TM) Sales through Peruvian Pharmacies and Scales up Exports to Brazil

GlobeNewswire October 8, 2020

RAMM Pharma Announces Approval and Registration of Epifractán(TM) 2% by Peru's Ministry of Health

GlobeNewswire July 16, 2020

RAMM Pharma Announces Approval and Registration of Epifractán(TM) 5% by Peru's Ministry of Health and Enters Distribution Agreement to Supply Pharmacies in Peru

GlobeNewswire July 9, 2020

RAMM Pharma announces its quarter financial results for Q2 2020

GlobeNewswire June 29, 2020

RAMM Pharma Corp. Announces Intention to Commence Normal Course Issuer Bid

GlobeNewswire April 15, 2020

RAMM Pharma Corp. Announces Postponement of Filing of Interim Financial Statements

GlobeNewswire March 30, 2020

IIROC Trade Resumption - RAMM

Canada NewsWire March 26, 2020

RAMM Pharma Corp. Receives Federal Approval and Registration of XALEX(TM) 10 (cannabidiol) Oral Solution

GlobeNewswire March 26, 2020

IIROC Trading Halt - RAMM

Canada NewsWire March 25, 2020

RAMM Pharma Corp. Provides Details on Operational Activities to Support COVID-19 Medical Response Effort & Corporate Update

GlobeNewswire March 23, 2020

RAMM Pharma Corp. to Acquire NettaLife, a Leading Developer of Cannabis-Based Products for Pets and Large Animals

GlobeNewswire February 25, 2020

RAMM Pharma Corp. Welcomes Legalization of Medical Cannabis in Brazil

GlobeNewswire December 5, 2019

CSE New Listing - RAMM Pharma Corp. Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com

Newsfile November 11, 2019

New Listing Alert: RAMM Pharma (C.RAMM) Now Trading on the CSE

Featured Submission November 8, 2019

RAMM Pharma Corp. Commences Trading on the Canadian Securities Exchange Under Ticker Symbol "RAMM" and Provides Corporate Update

GlobeNewswire November 8, 2019